New combo therapy shows promise for advanced prostate cancer
NCT ID NCT03361735
First seen Apr 15, 2026 · Last updated May 24, 2026 · Updated 7 times
Summary
This study tests a combination of three treatments for prostate cancer that has spread to a few spots in the body. The treatments are a radioactive drug (radium-223), hormone therapy to lower testosterone, and precise radiation to tumors. The goal is to see if this triple approach works better at controlling the cancer. About 25 adults with this type of prostate cancer are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.